title: [Prolonged treatment of recurrent neurocysticercosis using sequential doses of albendazole and praziquantel].
authors.forename: A
authors.initials: A
authors.lastname: Chagnon
authors.forename: M
authors.initials: M
authors.lastname: Galzin
authors.forename: J P
authors.initials: JP
authors.lastname: de Jaureguiberry
authors.forename: B
authors.initials: B
authors.lastname: Boyer
authors.forename: J F
authors.initials: JF
authors.lastname: Paris
authors.forename: S
authors.initials: S
authors.lastname: Marlier
authors.forename: P
authors.initials: P
authors.lastname: Carli
mesh_terms: D000328:Adult; D015766:Albendazole / Q000008:administration & dosage / Q000627:therapeutic use*; D001927:Brain Diseases / Q000188:drug therapy* / Q000469:parasitology*; D003551:Cysticercosis / Q000188:drug therapy*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D011223:Praziquantel / Q000008:administration & dosage / Q000627:therapeutic use*; D012008:Recurrence; D013118:Spinal Cord Diseases / Q000188:drug therapy* / Q000469:parasitology*
chemical_list: D011223:Praziquantel; D015766:Albendazole
vernacular_title: Traitement prolongé d'une neurocysticercose récidivante par cures sequentielles d'Albendazole et de Praziquantel.